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Hepatitis B virus-infected patients frequently have viral particles with DNA derived from differently spliced RNA. Which
factors influence the synthesis of these splice variants is unclear. We analysed the type of splice variants produced from
different genotypes and determined whether they are secreted as efficiently as wild-type virus. We demonstrate production
of a single splice variant from genotypes D, C, and E as dominant species in two hepatoma cell lines. The type of minor splice
variants synthesised varied between genotypes but was identical in both hepatoma cell lines. A novel splice variant with a
deletion in the core gene was identified for genotype D. Viral DNA from intracellular compared with extracellular viral
particles was spliced approximately five times more often than wild-type-sized genomes. A variable amount of the major
splice variant was also identified in sera from patients infected with genotypes A, D, and C. These data indicate genotype A-,
C-, D-, and E- as well as hepatoma cell line-independent synthesis of a dominant single splice variant and argue for a
biological function of the corresponding splice sites. This study clearly demonstrates the intracellular accumulation of viral
particles containing spliced genomes and offers a tool for the investigation of underlying mechanisms. © 2000 Academic PressINTRODUCTION
Substantial sequence heterogeneity of hepatitis B vi-
rus (HBV) genomes in viral particles isolated from sera
and livers of infected patients becomes increasingly ev-
ident in recent studies (reviewed in Gu¨nther et al., 1999).
The sequence heterogeneity of HBV genomes is mainly
based on the fact that synthesis of the partially double-
stranded circular HBV DNA genome involves reverse
transcription of an RNA pregenome that is mediated by
the virus-encoded P protein (reviewed in Ganem, 1996;
Nassal and Schaller, 1996; Nassal, 1999). Because re-
verse transcriptases lack proofreading activity and have
an intrinsic property for template switches, point muta-
tions and deletions/insertions are often created during
this process. The sequence heterogeneity of HBV full-
length genomes led to the classification of HBV into six
different genotypes named genotype A to F with distinct
prevalences in different geographical regions (reviewed
in Pult et al., 1998). The intergroup sequence divergence
of the different HBV genotypes varies between about 8%
and 14%, whereas the intragroup divergence is consid-
erably smaller (about 1–4%) (Norder et al., 1994). Whether
the sequence heterogeneity of different HBV genotypes
influences the viral life cycle or the outcome of an HBV
infection is currently under investigation (Mayerat et al.,
1999). Genotype-independent point mutations, inser-
tions, and deletions were identified in a large variety of
so-called variants, and some of them were shown or are1 Fax: 49-40-48051222. E-mail: will@hpi.uni-hamburg.de.
371believed to be associated with a specific course of in-
fection, vaccine, and antiviral therapy failure (reviewed in
Ngui et al., 1999; Gu¨nther et al., 1999; Pult et al., 1998).
One class of HBV genome variants, the so-called
splice variants, derives from encapsidation and reverse
transcription of spliced RNA pregenomes. Such variants
were isolated from sera and liver biopsies of chronically
infected patients as well as from transfected hepatoma
cells (Terre et al., 1991; Rosmorduc et al., 1995; Gu¨nther
et al., 1997). The presence of a specific splice variant
was reported to be closely associated with the chronic
course of HBV infection and viral multiplication in vivo
(Rosmorduc et al., 1995). However, analysis of viral ge-
nomes with mutations in two frequently used splice sites
revealed no effect on viral replication in transfected hep-
atoma cell lines (Su et al., 1989; Wu et al., 1991). Although
splicing of the HBV pregenome appears not to be essen-
tial for viral replication in vitro, other aspects of the viral
life cycle may be affected but have not been analysed so
far. In fact, a spliced mRNA of the HBV-related duck
hepatitis B virus (DHBV) has recently been shown to be
functionally important for virus replication in infected
primary duck hepatocytes and ducks but not for virus
formation in cells transfected with viral genomes (Obert
et al., 1996). In contrast to HBV, in DHBV splicing appears
to be much less complex because only two spliced RNAs
were found so far (Obert et al., 1996). In addition, none of
these mRNAs are encapsidated and reverse transcribed
due to the deletion of one or both known encapsidation
signals on the pregenomes by these splicing events
(Obert et al., 1996). Therefore, it is questionable whether
0042-6822/00 $35.00
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372 SOMMER, VAN BO¨MMEL, AND WILLsplicing has the same meaning in DHBV and HBV. For
HBV, 11 smaller than full-length genomes with single,
double, and triple splice deletions were isolated and
characterized so far from viral particles of sera from
chronically infected patients (Terre et al., 1991; Rosmor-
uc et al., 1995; Gu¨nther et al., 1997). In addition, for the
oodchuck hepatitis B virus (WHV), two differently
pliced genomes were found in sera and livers of chron-
cally infected woodchucks (Hantz et al., 1992; Ogston et
l., 1992).
An argument for the possible biological importance of
plicing in HBV is the conservation of eight of the nine
nown functional splice donor and acceptor sites in all
nown HBV genotypes (Gu¨nther et al., 1997). However,
the prevalence of viral particles with spliced genomes
appears to vary from patient to patient (Gu¨nther et al.,
1997; Rosmorduc et al., 1995). In addition, the ratio of
splice variants to wild-type virus in sera and livers of
HBV-infected patients as well as in WHV-infected wood-
chucks seems to be variable and to be higher in livers
than in sera (Terre et al., 1991; Hantz et al., 1992).
hether the variable amounts of splice variants are due
o host- and/or virus-specific factors is an open question.
o address this question, we investigated in vitro under
efined conditions which types of splice variants are
ynthesised from different genotypes and whether viral
articles containing spliced genomes are as efficiently
ecreted as those containing wild-type genomes. To
tudy the possible effects of host factors on HBV splice
ariant production, we representatively used two hepa-
oma cell lines that differ in both the genetic make-up
nd differentiation and analysed sera from patients in-
ected with different genotypes.
RESULTS
enome size analysis of HBV populations derived
rom genotype D-transfected Huh7 cells
To analyse the size heterogeneity of HBV genome pop-
lations that arises from a defined HBV genome sequence,
uh7 cells were transfected with HBV genotype D ge-
omes. After transfection, the viral DNA was isolated from
oth viral nucleocapsids of the cytoplasm and viral particles
eleased into the cell culture medium. Thereafter, a full-
ength HBV genome amplification of the DNA was per-
ormed using PCR primers that anneal to the nick region of
he HBV genome as described previously (Gu¨nther et al.,
995). The amplification products were electrophoretically
eparated in an agarose gel and stained by ethidium bro-
ide. As expected, amplified HBV genomes of 3.2-kb wild-
ype length were detected in both the cytoplasm and the
ulture medium (Fig. 1A, lanes HBV genomes, c and m). In
ddition to the HBV genomes of wild-type length, four am-
lification products with a higher electrophoretic mobility
ere visible (Fig. 1A, lanes HBV genomes, c and m). Clon-
ng and sequencing of these amplification products re-
d
1ealed that the major amplification products were 2.0 and
.6 kb long, respectively; each represents defective HBV
enomes containing single large internal deletions derived
rom spliced and reverse transcribed RNA pregenomes
Fig. 2, genomes designated sp1 and sp2). The additional
horter amplification products with a higher electrophoretic
obility than wild-type length were refractory to cloning
Fig. 1A, marked as hd1 and hd3). These bands are created
rtificially by heteroduplex (hd) formation of full-length and
p1 and sp2 HBV DNA, respectively, as shown by coampli-
ication of the corresponding cloned HBV DNAs (Fig. 1B, 30
ycles, hd1, hd2, and hd3). Note that these heteroduplex
olecules become increasingly visible after extensive am-
lification (Fig. 1B, compare lanes 25 and 30 cycles). Am-
lification of cloned HBV genomes of 3.2 kb did not result in
ands corresponding to heteroduplex formation, which ex-
ludes the possibility that genomes with deletions were
reated artificially during PCR (Fig. 1B). Taken together,
hese data demonstrate that the dominant type of HBV
enomes in viral particles from cytoplasm and culture me-
FIG. 1. (A) Gel electrophoretic analysis of HBV genomes derived from
Huh7 cells transfected with plasmid pSM2, genotype D. Viral DNA
isolated from viral nucleocapsids of the cytoplasm (c) or from virions of
the cell culture medium (m) were amplified with primer pair P1/P2 for
25 cycles, separated in an agarose gel, and stained by ethidium
bromide. Transfection was performed in doublets (lanes c1, c2, and m1,
m2) and in independent experiments (data not shown). Input-DNA
contamination was controlled by transfection with a replication incom-
petent HBV monomer containing construct (plasmid pHBV1). Lane M,
DNA size marker; lane N, mock transfection with herring-sperm DNA.
(B) Creation of HBV DNA heteroduplex molecules (marked as hd1, hd2,
and hd3) by coamplification of wild-type length genomes and spliced
genomes. Amplification was performed with primer pair P1/P2 for 25
and 30 cycles. Amplification products were separated in an agarose
gel and stained by ethidium bromide.ium of genotype D-transfected Huh7 cells are 3.2, 2.0, and
.6 kb in size.
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373HBV SPLICINGStructural analysis by cloning and sequencing of HBV
genomes derived from genotype D-transfected Huh7
cells
To characterize the amplification products, a detailed
structural analysis was performed by cloning of the en-
FIG. 2. (A) Structure and length of HBV genomes synthesized in Hu
pliced (sp1 to sp4) genomes isolated from viral nucleocapsids of the c
re given for the exon boundaries. Known viral protein coding regions
hereas open reading frames of unknown significance are gray. The pe
n) obtained from viral particles of the cytoplasm and culture medium
nd the corresponding putative branch sites and pyrimidine stretch po
n the consensus sequences for the splice acceptor (YAG/G) and putativ
991). Nucleotides of the polypyrimidine stretch are in italics.tire amplified viral DNA obtained from the cytoplasm and
the culture medium. The HBV DNA length of all recom-binants received was then first determined by PCR
screening using the full-length HBV genome primers.
Thus 27 and 56 recombinants obtained with the cyto-
plasm- and culture medium-derived viral DNA, respec-
tively, were analysed. This screening revealed that 5 of
transfected by plasmid pSM2, genotype D. Wild-type length (wt) and
m or secreted virions of the cell culture medium. Nucleotide positions
type of genome are depicted by capital letters (C, S1, S2, S, P, and X),
ge of the five different HBV genomes in the total number of HBV clones
n. (B) Sequence of the new HBV splice acceptor site at position 2236
y regulating its function. Letters in bold denote invariable nucleotides
h sites (YNYYRAY) (Mount, 1982; Zeitlin and Efstratiadis, 1984; Jackson,h7 cells
ytoplas
in each
rcenta
is give
tentiall27 (18%, cytoplasm) and 42 of 56 (75%, medium) plasmids
contained full-length HBV genomes (Fig. 2A), whereas
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374 SOMMER, VAN BO¨MMEL, AND WILLthe remaining recombinants all contained HBV DNA
smaller than wild-type size (Fig. 2A). The latter type of
genomes were further analysed by subgenomic PCRs
using primer pairs binding outside of previously de-
scribed intronic sequences (Gu¨nther et al., 1997, and
references therein) of the HBV genome (Fig. 2A, top).
This PCR screening indicated four types of HBV ge-
nomes smaller than wild-type length that all have dele-
tions upstream of nucleotide position 690 (data not
shown). To precisely identify the type and location of the
deletions in these defective genomes, a representative
recombinant of each size class was characterized by
sequencing. The sequence analysis revealed that all four
classes of smaller-than-full-length HBV genomes are de-
rived from spliced and reverse-transcribed HBV pre-
genomic RNAs (Fig. 2A, spliced genomes, sp1 to sp4).
Three of the four genome classes (sp1 to sp3) had a
single splice deletion, and one (sp4) had two splice
deletions. Spliced genomes sp1 to sp3 have been pre-
viously isolated from sera of patients (Terre et al., 1991;
Rosmorduc et al., 1995; Gu¨nther et al., 1997). The corre-
sponding splicing events involve splice donor sites at
positions 2067, 2447, and 2471 and the common splice
acceptor site at position 489 (Fig. 2A). No equivalent of
splice genome sp4 has so far been identified in the sera
or livers of infected patients. One of the deletions in
spliced genome sp4 is identical to that of genome sp1.
The other splice deletion is due to the use of a novel
splice acceptor site at position 2236 and of the identical
splice donor site used by spliced genome sp2 (Figs. 2A,
sp4, and 2B). This splicing event results in a 56-amino-
acid in-frame deletion of the viral core protein and leaves
the polymerase protein coding region untouched.
From the number and type of recombinants anal-
ysed, it appears that the ratio of full-length and spliced
genomes isolated from intracellular and extracellular
viral particles is drastically different. Provided the type
of genomes obtained by amplification and cloning
fairly accurately reflects the ratio of their presence in
the intracellular and extracellular viral population, the
following conclusion can be made. The two major
singly spliced genomes sp1 and sp2 are more preva-
lent in the viral particles isolated from the cytoplasm
than are those from the culture medium, whereas the
reverse is true for the full-length HBV genomes (Fig.
2A). Accordingly, the major spliced genomes appear to
represent about 20% of the genome population iso-
lated from the culture medium and about 80% of the
cytoplasmatic genome population (Fig. 2A). In con-
trast, spliced genomes sp3 and sp4 appear to be very
rarely synthesized. A conclusion about their absolute
prevalence and possible differences between cyto-
plasm and cell culture medium is not possible be-
cause of the few clones obtained.Determination of the ratio between wild-type length
and spliced HBV genomes by semiquantitative
analysis
A higher prevalence of smaller-than-full-length HBV
genomes in infected liver compared with the serum of
individual patients was reported previously (Sommer et
al., 1997) and is suggested by studies by Terre et al. (see
ig. 3 in Terre et al., 1991). These findings, as well as our
emiquantitative results obtained by characterisation of
he recombinants (Fig. 2A), prompted us to analyse
hether spliced genomes are indeed more prevalent in
iral particles isolated from the cytoplasm of transfected
uh7 cells. This should be evident in a semiquantitative
nalysis of amplification products after separation by
garose gel electrophoresis and ethidium bromide stain-
ng (Fig. 1A). This type of analysis is meaningful because
e used a high concentration of template molecules,
eading to reproducible banding patterns, a minimum
umber of amplification cycles, and a Taq/Pwo-DNA-
olymerase mixture. All of these safeguards guarantee
imilar amplification efficiency of HBV genomes that vary
n size as experimentally determined previously through
he use of defined mixtures of cloned wild-type and
pliced genomes as templates (Sommer et al., 1997).
With densitometric scanning of the corresponding
ethidium bromide-stained bands, we found that the total
HBV DNA population in the cytoplasm consisted of about
31% full-length HBV genomes, of 46% sp1 genomes, and
of 23% sp2 genomes (Fig. 3A). In contrast, in the culture
medium, the full-length genomes represented 75%, the
sp1 genomes represented 19%, and the sp2 genomes
represented 6% of the total genome population (Fig. 3B).
FIG. 3. Ratio of wild-type length (wt) and the predominant spliced
genomes (sp1 and sp2) isolated from viral particles from cytoplasm and
cell culture medium of genotype D transfected Huh7 cells. The signal
intensity of the 3.2-, 2.0-, and 1.6-kb ethidium bromide-stained bands in
Fig. 1A was determined densitometrically, and the corresponding per-
centage of the different viral genomes was calculated by setting the
total HBV genome population to 100%.These values are similar to those deduced from the type
and number of HBV recombinants (see above). Amplifi-
375HBV SPLICINGcation of HBV DNA from cytoplasmic and cell culture-
derived particles obtained by transfection of a replica-
tion-incompetent wild-type-length HBV genome resulted
only in a very weak 3.2-kb band when using DNA from
the culture medium (Fig. 1A). This indicates that very little
input DNA from the culture medium and none from the
cytoplasm are amplified, suggesting a rather accurate
evaluation of the ratios of newly produced viral DNA in
the cytoplasm and culture medium by the method used.
Taken together, our semiquantitative analysis of amplifi-
cation products on agarose gels and of recombinants
revealed an approximately five times higher ratio of wild
type length to singly spliced genomes in extracellular
versus intracellular viral populations. Therefore, it ap-
pears that nucleocapsids containing wild-type-length ge-
nomes are preferentially enveloped or released from the
cells, whereas those containing spliced genomes accu-
mulate in the cytoplasm.
Analysis of HBV genotype- and cell line-dependent
size heterogeneity of viral genome populations
To analyse whether viral genomes of different geno-
types and/or host factors such as the genetics and dif-
ferentiation status of hepatoma cell lines influence the
size heterogeneity and splicing pattern of HBV genomes,
we transfected Huh7 and HepG2 cells with viral ge-
nomes of genotypes D, C, and E. The three genotypes
that we tested diverge by sequence by more than 8%
(genotype D to E, 8.4%; D to C, 10.9%; and C to E, 11.0%).
After transfection of Huh7 and HepG2 cells with ge-
nomes of genotype E, C, and D, respectively, the corre-
sponding de novo produced HBV genome populations
were isolated from the intracellular viral nucleocapsids.
Amplification with the full-length genome primers and
analysis of the products on agarose gels showed similar
ratios of full-length and sp1 genomes obtained from both
cell lines and with all three genotypes. However, there
were clear differences in bands corresponding to ge-
nomes smaller than spliced genome sp1 (data not
shown). These differences were identical and reproduc-
ible in both cell lines (data not shown), arguing that they
are due to genotype-specific sequence differences but
not to cell type-specific factors. To analyse the type of the
genotype-dependent genomes smaller than spliced ge-
nome sp1, we performed subgenomic PCRs with primers
that should detect all types of known spliced genomes
(Fig. 4, top). As expected, each of the three HBV geno-
types resulted in a specific and slightly different banding
pattern. This pattern did not differ between both cell lines
(Fig. 4A), confirming genotype-specific genome size dif-
ferences independent of the cell line used. The use of
primers P3 and P4, which amplify DNA fragments from
all known spliced genomes, consistently amplified a
fragment of 829 bp. This corresponds to spliced genome
sp1 as indicated by the comigration of the product am-plified from a cloned sp1 genome (Fig. 4A, lane sp1).
Because spliced genome sp3 differs from sp1 by only 24
nucleotides, this was confirmed by an additional sub-
genomic PCR with primers P4 and P5 (Fig. 4B, lanes sp1
and sp3). Primers P3 and P4 resulted in amplification
products of 449 bp when using DNA from genotype E
and D but not from genotype C. This fragment corre-
sponds to spliced genome sp2 as evident from comigra-
tion of the same fragments amplified from a cloned sp2
genome (Fig. 4A, lane sp2). The use of primers P3 and
FIG. 4. Agarose gel analysis of smaller-than-full-length genomes
produced by genotypes E, C, and D and amplified by subgenomic
PCRs. Top, Schematic outline of the structure of the four spliced
genomes identified for genotype D and type of primer pairs used for
amplification. (A–C) Amplification product obtained with the various
primer pairs and DNA present in Huh7 and HepG2 cells transfected
(Fugene Reagent) with three different genomes (lanes 1–3) of geno-
types E and C or monomeric (m) and dimeric (d) genomes of genotype
D. Lanes sp denote amplification products obtained with cloned
spliced genomes sp1 to sp4. DNA fragments that probably correspond
to splice variants of unknown structure are marked by arrows. In lanes
N, amplification products obtained with DNA from mock-transfected
cells (herring-sperm DNA) were loaded.P6, which resulted with genotype D-derived DNA only in
products with the size predicted for genomes without a
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376 SOMMER, VAN BO¨MMEL, AND WILLdeletion in this region and in no product with spliced
genome sp2, supports this conclusion (Fig. 4C, lanes sp2
and genotype D, m and d). Genotype E- and C-specific
amplification products of about 600 and 550 bp, respec-
tively, were obtained with primers P3 and P4 (Fig. 4A,
bands marked with arrows). The origin of these bands is
not clear, but the size of the amplification products ob-
tained with primer pairs P3/4 and P3/6 (Fig. 4C, about
350 and 330 bp) suggests that they are derived from
genomes that have at least two deletions, one of them
occurring in the core region (Fig. 4C, lanes genotype E
and C). Because these two bands also did not comigrate
with an amplification product obtained from cloned
spliced genome sp4, we have to assume there is a splice
in the core region that is different from that in the core
region of sp4 (Figs. 4A and 4C). Taken together, these
data demonstrate that HBV genomes of all three geno-
types tested produce the singly spliced genome sp1 with
similar efficiency, whereas other smaller-than-full-length
genomes are not common to all genotypes. In addition,
the genotype-specific synthesis of spliced genomes was
independent of the cell line used.
To also provide evidence for the in vivo synthesis of
the dominant spliced genome sp1 from different geno-
types, we analysed sera of patients chronically infected
with genotypes A, C, D, and E as evident from sequenc-
ing of the amplified HBV DNA (data not shown). For
identification of spliced genomes in these sera, the viral
DNA was amplified by PCR, separated by agarose gel
electrophoresis, and stained by ethidium bromide. Bands
corresponding in size to spliced genomes sp1 (and ver-
ified by cloning and sequencing, data not shown) could
thus be visualized with viral DNA from sera of patients
infected by HBV of genotypes A, D, and C (Fig. 5; for
representative examples, see lanes A, D, and C). How-
FIG. 5. Gel electrophoretic analysis of HBV genomes derived from
atients chronically infected with different HBV genotypes. Viral DNA
solated from patient sera was amplified with primer P1/2, separated in
n agarose gel, and stained by ethidium bromide. Lanes loaded with
iral DNA of genotypes A, D, C, and E are depicted by large letters. The
ighest level of spliced genomes sp1 relative to nonspliced genomes
wt) we detected by screening of sera is shown in lane C9 and stems
from a patient infected with HBV genotype C.ever, by screening several patients infected with these
genotypes, we did not find in all sera spliced genomes(data not shown), indicating that the fraction of spliced
genomes in the total virus population is highly variable
and often below the detection limit of our method. Inter-
estingly, we noted even variation of the relative amount
of sp1 genomes during the chronic course of infection,
as exemplarily shown for viral DNA of genotype C iso-
lated from two sera that were taken at different time
points from the same patient (Fig. 5, compare lanes C
and C9). In addition, the testing of 13 samples of sera
from patients infected with HBV of genotype E did not
result in visible bands corresponding to sp1 genomes
(Fig. 5; see lane genotype E for a representative exam-
ple). Therefore, analysis of additional sera from genotype
E-infected patients is necessary to determine whether
genotype E produces in vivo either no sp1 genomes or
much less than other genotypes. However, the highly
variable level of sp1 genomes in HBV genotype A-, D-,
and C-containing sera, which ranged from nondetectable
up to at least 20% as roughly estimated from the signal
intensity of the ethidium bromide-stained bands, and the
demonstration that in vitro genotype E produces sp1
genomes as efficiently as other genotypes (Fig. 4), argue
against a principle defect of sp1 genome synthesis by
genotype E in vivo.
DISCUSSION
In this study, we analysed in hepatoma cells the type
of spliced HBV genomes produced intracellularly and
shed into the culture medium, as well as possible effects
exerted on splicing by genotype-specific sequence dif-
ferences and the type of cell line used. We demonstrate
that one defective genome with a single splice is pro-
duced as the most dominant subpopulation of smaller-
than-wild-type-length genomes by genotypes D, C, and E
in vitro and by genotypes A, C, and D in vivo. None of the
other defective genomes are produced consistently by
all of these genotypes. The synthesis of spliced and
defective genomes was shown to be independent of the
cell line used. Furthermore, we identified a novel splice
variant that increases the number of known functional
HBV splice acceptor sites from four to five. We also found
that the percentage of spliced genomes of the total
genome population is higher in intracellular than in ex-
tracellular viral particles. Taken together, our data argue
for a role of the genotype-independent major splice do-
nor and acceptor site, but not of minor sites, in the life
cycle of the virus. Moreover, our data demonstrate com-
plex HBV splicing events as well as intracellular accu-
mulation of spliced genomes in hepatoma cells similar to
reports on in vivo situations. Our findings imply that
hepatoma cells are useful tools for the investigation of
basic aspects of HBV splicing, which is so far a largely
neglected field of research.The genotype D-, E-, and C-independent dominant
spliced genome contains a deletion due to a splicing
1377HBV SPLICINGevent between nucleotide positions 2447 and 489. The
same spliced genome was identified previously as a
major viral subpopulation in sera and liver biopsy sam-
ples of several chronically infected patients (Terre et al.,
1991; Rosmorduc et al., 1995; Gu¨nther et al., 1997). In one
of these reports, this spliced genome was obviously
produced in vivo from genotype A (Gu¨nther et al., 1997).
Our data confirmed this and showed in addition the
presence of spliced genome sp1, also in sera of patients
chronically infected with genotypes C and D. Therefore,
this splicing event is common at least for four different
genotypes, which further supports the likely role of the
corresponding splice sites for the biology of HBV. How-
ever, our data obtained with human sera also strongly
suggest that in vivo host factors and possibly also the
sequence heterogeneity of the viral populations can sig-
nificantly affect the steady-state levels of spliced ge-
nome-containing viral particles. Identification of these
factors and knowledge about the biological function of
this splice event will probably depend on the use of
animal systems and infection experiments with splice
site knockout mutant viruses for the following reasons. A
mutation of the splice acceptor site at nucleotide posi-
tion 489 was previously shown not to affect viral replica-
tion in vitro (Su et al., 1989). However, the same was
observed with a splice site knockout mutant of DHBV, but
the mutation had a significant effect on infection in vivo
(Obert et al., 1996). Similar to the dominant spliced mRNA
of DHBV, the major spliced HBV mRNA lacking intron
2447/489 can represent up to 30% of the pre-C/C tran-
scripts as revealed in transfected hepatoma cells, in the
liver of chronically infected patients, and in HBV trans-
genic mice (Su et al., 1989; Suzuki et al., 1989; Choo et al.,
991; Kajino et al., 1991; Terre et al., 1991; Wu et al., 1991).
Consistent with these findings, our study has shown for
genotype D that approximately 50% of all intracellular
genomes represent the genotype-independent major
spliced genome. Unlike in HBV, which has only one
encapsidation signal, the dominant spliced mRNA of
DHBV is not encapsidated due to the deletion of one of
the two encapsidation signals by the splicing event,
which prevents synthesis of the corresponding spliced
genomes. Therefore, if the major DHBV and HBV splice
events have a similar function, it is conceivable that it is
not the synthesis of spliced genomes of HBV, which is
biologically relevant, but the corresponding mRNAs
and/or splice sites. In support of this speculation is a
recent report that suggests a function of the major splice
acceptor site and upstream sequences in posttranscrip-
tional export of viral transcripts (Putlitz et al., 1999).
Therefore, the recognition of splice sites and upstream
sequences by the splice apparatus, but not the splicing
per se, may play a role in the viral life cycle. On the other
hand, the proteins synthesized from the spliced tran-
scripts may have a functional role in the viral life cycle
and the course of infection. Consistent with this specu-lation, the major HBV spliced genome sp1 transfected
into hepatoma cells was previously shown to lead to
increased levels of X transcripts, large amounts of se-
creted HBeAg, and intracellular accumulation of core
protein compared with cells transfected with wild-type
genomes (Rosmorduc et al., 1995). In addition, a novel
viral protein translated from the sp1 spliced mRNA was
recently detected in liver biopsy samples of patients with
HBV-related cirrhosis and was shown to induce apopto-
sis in vitro (Soussan et al., 2000). These and our findings,
as well as the more frequent detection of the spliced
genomes in chronically compared with acutely infected
patients, support the previous suggestion that splicing
may contribute to the pathogenicity and/or persistence of
HBV (Rosmorduc et al., 1995; Soussan et al., 2000).
Genotype-specific differences in the synthesis of ge-
nomes smaller than wild-type length became apparent in
our study, which implies that some minor splice sites are
functional or highly active only in specific genotypes. The
most striking example is represented by genotype C,
which showed no common minor spliced genome with
genotypes D and E, except for the dominant spliced
genome sp1 (Fig. 4A, lanes genotype C). These differ-
ences in splicing between genotypes D/E and C cannot
be due to mutations of the known 10 splice donor and
acceptor sites because all, except one, are conserved as
evident from sequence inspection (data not shown and
Gu¨nther et al., 1997). The exception concerns the splice
donor site at nucleotide position 2087, which is exclu-
sively present in genotype C but mutated in genotypes D
and E (Gu¨nther et al., 1997). This may imply that the
unique amplification products obtained with genomes of
genotype C and primer pairs 3/4 and 3/6 (Figs. 4A and
4C) may correspond to doubly spliced genomes derived
from mRNAs that were spliced at this unique donor site
combined with other acceptor sites. The structure of a
doubly spliced mRNA present in liver infected with ge-
nomes of genotype C and in transfected hepatoma cells
as reported previously (Chen et al., 1989; Wu et al., 1991)
and the size of the amplification products obtained are
consistent with this speculation or use of the very prox-
imal splice donor site 2067. Because no evidence for the
production of sp2 genomes, which are synthesized from
genotypes D and E, was obtained for genotype C, the
splice donor site at position 2067 appears to be nonfunc-
tional in genotype C in combination with the splice ac-
ceptor site at position 489. This may be due to mutations
in the corresponding branch site and/or polypyrimidine
stretch necessary for splicing, as supported by the fact
that genotype C sequences differ more from genotype D
and E (about 11.0%) than D differs from E (about 8%) (our
data, and Norder et al., 1994). Swapping experiments
with fragments of different genotypes and mutational
analysis will be necessary to confirm these assumptions.In addition to the previously described five splice do-
nor and four splice acceptor sites known to remove
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378 SOMMER, VAN BO¨MMEL, AND WILLintronic sequences from the viral RNA pregenome (Chen
et al., 1989; Su et al., 1989; Suzuki et al., 1989, 1990; Choo
t al., 1991; Wu et al., 1991; Gu¨nther et al., 1997), we
dentified a new functional splice acceptor site at posi-
ion 2236 in genotype D genomes. In the corresponding
pliced genome, the splice acceptor site at position 2236
s used in combination with the splice donor site at
osition 2067 and results in an in-frame deletion of the
iral core gene. This splice event may contribute to the
ccumulation of C-gene deletion variants similar as ob-
erved in long-term immunosuppressed patients and
hown to be associated with progressive liver disease
Gu¨nther et al., 1996; Preikschat et al., 1999).
An interesting finding of our study was that in vitro, the
atio between wild-type and spliced genomes differed
ramatically between viral particles isolated from the
ntracellular compartment and those from the extracellu-
ar space. The intracellular genome population consisted
redominantly of spliced HBV genomes, whereas extra-
ellular particles contained predominantly wild-type
ength genomes. An accumulation of encapsidated
pliced genomes in the cytoplasm implies that these
efective genomes are efficiently trans-complemented
y P-protein derived from wild-type HBV genomes. The
act that for propagation spliced genomes need to be
nd can be trans-complemented by viral P-proteins was
hown by cotransfection of spliced genomes with defec-
ive wild-type length genomes that lack a functional en-
apsidation signal (Rosmorduc et al., 1995). However, in
itro the P-protein has also been shown to act primarily
n cis; that is, pregenomic RNAs from which P-protein is
ynthesized are preferentially encapsidated (Barten-
chlager et al., 1990). Therefore, the similar high amount
f spliced genomes in sera of chronic carriers and in cell
ulture media of transfected hepatoma cells (our data
nd Terre et al., 1991; Rosmorduc et al., 1995; Gu¨nther et
l., 1997) suggests that in vivo and in vitro, the P-protein
is expressed in excess from wild-type genomes and
allows efficient packaging of spliced pregenomic RNA.
The intracellular accumulation of viral nucleocapsids
containing spliced genomes strongly suggests that com-
pared with those containing spliced genomes, nucleo-
capsids containing wild-type length genomes are prefer-
entially enveloped or released from the cell. This is
probably similar in vivo as suggested by a report dem-
onstrating the accumulation of the major spliced genome
sp1 compared with wild-type length genomes in liver
samples of chronically infected patients (Terre et al.,
1991). Further support for this conclusion comes from an
independent study that revealed a higher relative amount
of smaller-than-full-length HBV genomes in the infected
livers than in the corresponding sera (Sommer et al.,
1997). In addition, spliced genomes of the WHV were
detected less prevalently in sera compared with the liver
biopsy samples of chronically infected woodchucks
(Hantz et al., 1992). These findings and our results raise
g
athe question as to the mechanism leading to preferential
intracellular accumulation of viral particles with spliced
genomes. Previous studies with DHBV and HBV have
revealed a strong bias in favor of the export of viral
particles with genomes that have completed minus-
strand synthesis and at least initiated plus-strand syn-
thesis (Gerelsaikhan et al., 1996; Wei et al., 1996). Be-
cause the successful amplification of spliced genomes
by the PCR technique that was used requires the pres-
ence of completed DNA minus strands in the viral parti-
cles but not synthesis of DNA plus strands, it is conceiv-
able that spliced RNAs are reverse-transcribed into DNA
minus strands only. Therefore, the corresponding nu-
cleocapsids may accumulate intracellularly because
they cannot mature to an extent that leads to the appear-
ance of a signal on the surface needed for efficient
envelopment and subsequent secretion. Alternatively
and more likely, DNA plus-strand synthesis of spliced
DNA minus strands may not be hampered, and it is a
difference in the structure of the spliced DNA that hin-
ders maturation of the viral particles.
One of the possible differences between full-length
and spliced HBV DNA-containing nucleocapsids in en-
velope acquisition may be phosphorylation of the core
proteins. This could lead to enhanced attachment of the
nucleocapsid to the nuclear pore (Kann et al., 1999),
ossibly resulting in enhanced nuclear import of the
pliced genomes, and its conversion into cccDNA. Thus
pliced RNAs without the contribution of the splicing
pparatus may be synthesized from this cccDNA. This
ay in part explain the previously published indications
or a higher prevalence of spliced genomes in chronic
BV carriers compared with acutely infected patients
Rosmorduc et al., 1995) provided the accumulation of
pliced DNA in the form of nuclear cccDNA takes some
ime. One consequence of nuclear entry and repair of
pliced DNA genomes could be the accumulation of the
orresponding cccDNA. Provided this type of cccDNA
ccumulates to a similar level and has a similar patho-
enic effect as enhanced levels of cccDNA made from
ull-length HBV DNA, as suggested from experiments
erformed with a pre-S mutant of DHBV (Summers et al.,
990; Lenhoff et al., 1999), spliced genomes may indi-
ectly also contribute to hepatopathogenicity. Testing of
hese hypothesis will require the use of primary human
epatocytes or the woodchuck model because cccDNA
ormation in hepatoma cells is very inefficient and does
ot occur in transgenic mice (Bock et al., 1994; reviewed
n: Chisari, 1995). In addition, a direct hepatopathogenic
ffect by the intracellular accumulation of spliced ge-
omes sp1 is conceivable because it may lead to an
nhanced expression of the recently described splice-
enerated viral protein (HSBP), which can induce cell
poptosis (Soussan et al., 2000).
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379HBV SPLICINGMATERIAL AND METHODS
ull-length amplification and cloning of HBV genomes
The full-length amplification of isolated viral DNA was
erformed in a Robocycler (Stratagene, La Jolla, CA) as
escribed previously (Gu¨nther et al., 1995) by using the
ycle number indicated and the Expand High Fidelity
CR System (Roche Diagnostics). The reaction mixture
onsisted of 50 ml of buffer containing 1.5 mM MgCl2, 200
mM dNTPs, 2.6 U of Taq and Pwo DNA polymerase
mixture, and 0.3 mM concentration of each primer. The
rimers contain sequences for restriction sites within
eterologous sequences at the 59-end (P1: 1821–1841
9-CCGGAAAGCTTGAGCTCTTCTTTTTCACCTCTGCC-
TAATCA; P2: 1823–1841 59-CCGGAAAGCTTGAGCTCT-
TCAAAAAGTTGCATGGTGCTGG; SstI and SapI restric-
tion sites are underlined) and hybridize at the nick region
of the genome. The position of the primer corresponds to
the nomenclature of HBV genotype D subtype ayw with
numbering starting in the middle of the EcoRI site (Gali-
bert et al., 1979).
For cloning of the amplified HBV genomes, the PCR
roducts were purified by phenol–chloroform extraction,
recipitated, dissolved in water, and digested in the
ppropriate buffer with SstI. The restriction fragments
ere purified by using the QIAquick PCR Purification Kit
Qiagen) and cloned into vector pUC19.
solation of DNA from sera of patients
DNA was isolated from 100 ml of serum by using the
IAamp Blood Kit (Qiagen). The DNA was eluted from
he spin column in a volume of 50 ml. The isolated DNA
as stored at 220°C until use.
lasmids containing HBV reference genomes of
ifferent genotypes
Plasmid pSM2 contains an EcoRI head-to-tail dimer of
enotype D, subtype ayw (Galibert et al., 1979), which
as cloned via EcoRI restriction sites into plasmid
Ma5-8 (Stanssens et al., 1989). pHBV1 contains a mono-
er of genotype D subtype ayw amplified by the full-
ength amplification technique and cloned via SstI into
ector pUC19 (Sommer et al., 1997).
For isolation of genomes derived from genotypes E
nd C, DNAs isolated from sera of two chronically in-
ected patients were amplified by the full-length amplifi-
ation technique for 20 cycles, cloned into vector pUC19,
nd sequenced. Sequence alignment of the cloned full-
ength genomes by BLAST search (MacVector 6.0.1) to
BV genomes in the NCBI database revealed the high-
st homology of pHBVC1, pHBVC2, and pHBVC3 with a
enome of genotype C (98% homology to HBV genome
F068756, Monkongdee et al., 1998) and of pHBVE1,
HBVE2, and pHBVE3 with a genome of genotype E (98%
omology to HBV genome HHVBBAS, Norder et al., D994). The three newly isolated HBV genomes of geno-
ype C diverge from each other by less than 6-point
utations, and those of HBV genotype E diverge by less
han 15-point mutations.
nalysis of amplified HBV genomes by subgenomic
CR and sequencing
For subgenomic PCRs, the purified viral DNAs or HBV
NAs in plasmid integrated form were amplified by run-
ing 40 cycles with denaturation at 94°C for 40 s, an-
ealing at 55°C for 40 s, and elongation at 72°C for 1
in. The PCRs were performed in a 25-ml assay contain-
ng 10 mM Tris–HCl (pH 8.3), 1.5 mM MgCl2, 50 mM KCl,
00 mM dNTPs, 1 U of Taq DNA polymerase, and 0.2 mM
concentration of each primer using combination P3/4
(P3: 1821–1841 59-TTTTTCACCTCTGCCTAATCA; P4: 690–
669 59-AATGGCACTAGTAAACTGAGCC), P4/5 (P5: 2359–
2384 59-CAGGTCCCCTAGAAGAAGAACTCCCT), and
P3/6 (P6: 2380–2359 59-AGTTCTTCTTCTAGGGGACCTG).
The positions of the primers correspond to the nomen-
clature of HBV genotype D subtype ayw (Galibert et al.,
1979).
The HBV DNA inserts of the recombinants were se-
quenced by using pUC19-specific reverse and forward
primers hybridizing to sequences flanking the cloned frag-
ments and by internally hybridizing HBV genome primers
(477–455 59-GGACAAACGGGCAACATACCTTG; 968–990
59-GGCCTATTGATTGGAAAGTATGTC; 1121–1100 59-AGAA-
GGCCTTGTAAGTTGGCG; 2357–2380 59-GGCAGGTC-
CCTAGAAGAAGAACT) using the SequiTherm Sequenc-
ng Kit (Epicentre Technologies) and an automated se-
uencer (LICOR).
ransfection of HBV DNA into human hepatoma cell
ines
The linear HBV monomer was released from the vector
y SapI digestion and transfected by calcium phosphate
recipitation into the hepatoma cell lines Huh7 and
epG2 as described previously (Gu¨nther et al., 1998).
lasmid pSM2 was transfected directly. Where indicated,
he HBV DNA was alternatively transfected by using the
ugene 6 Transfection Reagent (Roche Diagnostics) ac-
ording to the protocol of the supplier. The cells were
arvested 5 days (calcium phosphate precipitation) or 4
ays (Fugene Reagent) after transfection.
urification of intracellular and extracellular HBV DNA
roduced by transfected hepatoma cells
The cells were washed twice with PBS and lysed in
00 ml of lysis buffer (50 mM Tris–HCl, pH 7.4, 1 mM
EDTA, 1% Nonidet P-40) 60-mm diameter petri dish for 15
min. Nuclei were pelleted by centrifugation for 1 min at
14,000 rpm (Eppendorf centrifuge). The supernatant was
adjusted to 10 mM MgCl2 and treated with 100 mg/ml of
Nase I (Roche Diagnostics) for 30 min at 37°C. The
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380 SOMMER, VAN BO¨MMEL, AND WILLreaction was stopped by the addition of EDTA to a final
concentration of 25 mM. Proteins were digested for 2 h at
7°C in 1% SDS with 0.5 mg/ml of Proteinase K (Roche
iagnostics). The nucleic acids were purified by phenol–
hloroform (1:1) and chloroform extraction before ethanol
recipitation in presence of 12 mg/ml of glycogen (Roche
iagnostics) added as a carrier. The pellet was resus-
ended in water and stored at 220°C until use.
For purification of HBV DNA from extracellular viral
articles, the cell culture medium was clarified by cen-
rifugation (Sorvall SS34 rotor, 8000 rpm) for 30 min.
hree milliliters of the medium was laid on the top of a
-ml 20% sucrose cushion in TNE (10 mM Tris–HCl, pH
.4, 1 mM EDTA, 100 mM NaCl) and ultracentrifuged
Beckman SW50.1 rotor, 45,000 rpm). The pellet was
esuspended in 500 ml of 50 mM Tris–HCl (pH 8.0), and
he DNA was extracted as described above.
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